Who is sponsoring NCT03799575?

NCT03799575 is sponsored by Hospital de Santa Maria, Portugal.

What drugs are being tested in NCT03799575?

Interventions in NCT03799575: Transmission Electron Microscopy analysis.

What condition does NCT03799575 study?

NCT03799575 studies C11.768.740.

Is NCT03799575 still recruiting?

NCT03799575 is currently status unknown. Last updated 10 January 2019.

Last reviewed 2019-01-10 · How we verify

NCT03799575

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Internal Limiting Membrane and Macular Hole

Status unknown Last updated 10 January 2019

What this trial tests

trial testing Transmission Electron Microscopy analysis in C11.768.740 in 10 participants. Status unknown.

Timeline

2 January 2019

Primary endpoint
2 July 2019

2 July 2019

Quick facts

Lead sponsor	Hospital de Santa Maria, Portugal
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	10
Start date	2 January 2019
Primary completion	2 July 2019
Estimated completion	2 July 2019
Sites	1 location across Portugal

Drugs / interventions tested

Transmission Electron Microscopy analysis

Conditions studied

C11.768.740 — all drugs for C11.768.740 →

Sponsor

Hospital de Santa Maria, Portugal

Who can join

Adults 18 to 90, any sex, with C11.768.740. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational study of Internal Limiting Membrane peeled in macular Hole surgery and studied by Transmission electronic Microscopy (TEM) and Optical Coherence Tomography (OCT) findings in closed holes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Morphology of Peeled Internal Limiting Membrane in Macular Hole Surgery.
Faria MY, Sousa DC, Almeida BC, Pinto AL, et al · · 2019 · cited 1× · PMID 31191990 · DOI 10.1155/2019/1345683

Verify or expand the search:

Other Hospital de Santa Maria, Portugal trials

Trials by the same sponsor.

NCT05070637 — Circulating Tumor Cell Reducing No-touch Nephrectomy · NA · completed
NCT04201249 — Mesotherapy In Lateral Epicondylitis · Phase 2, PHASE3 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03799575 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital de Santa Maria, Portugal
Last refreshed: 10 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03799575.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing